Burden A D, Beck M H
Skin Hospital, Salford, U.K.
Br J Dermatol. 1992 Nov;127(5):497-500. doi: 10.1111/j.1365-2133.1992.tb14847.x.
Topical corticosteroids are increasingly recognized as relatively common contact sensitizers. Between July 1988 and December 1991 2687 patients undergoing routine patch testing were also tested with tixocortol pivalate (TP). Over the same time period 528 patients were selected for testing with a series of 18 steroids. One-hundred and thirty-one cases (4.9%) of corticosteroid hypersensitivity were detected and 119 (90.8%) of these cases were positive to TP. Thirty-seven patients reacted to one or more steroids in the steroid series, the most frequent sensitizers being hydrocortisone, budesonide (3.6%) and hydrocortisone 17-butyrate (2.5%). Of these 37 cases, 20 (54%) reacted to more than one steroid simultaneously, but the patterns of cross-reaction were not consistent with previously suggested groupings. Screening for steroid allergy should be performed as part of standard patch testing. The value of TP as a marker of corticosteroid hypersensitivity is reinforced by this study, but no satisfactory marker was found for the 9.2% of cases not detected by TP. There remains a need for further markers of corticosteroid hypersensitivity. A prevalence of 4.9% of corticosteroid allergy amongst our patients suggests that the frequency of this finding is generally underestimated.
外用皮质类固醇越来越被认为是相对常见的接触致敏原。1988年7月至1991年12月期间,对2687例接受常规斑贴试验的患者也进行了匹伐硫考醇(TP)检测。在同一时期,选择了528例患者用18种类固醇进行检测。检测到131例(4.9%)皮质类固醇超敏反应病例,其中119例(90.8%)对TP呈阳性。37例患者对类固醇系列中的一种或多种类固醇有反应,最常见的致敏原为氢化可的松、布地奈德(3.6%)和氢化可的松17-丁酸酯(2.5%)。在这37例病例中,20例(54%)同时对一种以上类固醇有反应,但交叉反应模式与先前建议的分组不一致。类固醇过敏筛查应作为标准斑贴试验的一部分进行。本研究强化了TP作为皮质类固醇超敏反应标志物的价值,但对于9.2%未被TP检测到的病例,未发现令人满意的标志物。仍然需要更多皮质类固醇超敏反应的标志物。我们的患者中皮质类固醇过敏患病率为4.9%,这表明该发现的频率通常被低估。